We are live on ! Find out more
BC

Broadwood Capital Portfolio holdings

AUM $1.42B
1-Year Est. Return 34.72%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+34.72%
3 Year Est. Return
+45.97%
5 Year Est. Return
+44.27%
10 Year Est. Return
+866.96%
AUM
$1.3B
AUM Growth
-$18.7M
Cap. Flow
-$9.86M
Cap. Flow %
-0.76%
Top 10 Hldgs %
100%
Holding
7
New
Increased
Reduced
1
Closed

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
IWM icon
iShares Russell 2000 ETF
IWM
+$9.86M

Sector Composition

Rank Sector Weight
1 Healthcare 34.7%
2 Consumer Staples 33.2%
3 Industrials 23.3%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MNST icon
1
Monster Beverage
MNST
$94.3B
$433M 33.2%
8,295,690
STAA icon
2
STAAR Surgical
STAA
$1.21B
$400M 30.68%
10,768,431
AXON
3
Axon Enterprise
AXON
$42.5B
$304M 23.3%
760,062
IWM icon
4
iShares Russell 2000 ETF
IWM
$79.8B
$115M 8.81%
519,920
-46,080
-8% -$9.86M
LCTX icon
5
Lineage Cell Therapeutics
LCTX
$269M
$37.7M 2.89%
41,666,255
IMDX
6
Insight Molecular Diagnostics
IMDX
$150M
$14M 1.08%
4,929,066
SER icon
7
Serina Therapeutics
SER
$30M
$570K 0.04%
85,219

Similar funds

Broadwood Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Broadwood Capital held 7 positions worth $1.3B, down 1.4% from $1.32B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q3 2024: portfolio turnover was 0%. Broadwood Capital opened no new positions and made no exits, leaving the 7-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 35% of assets, down from 43% a quarter earlier, followed by Consumer Staples and Industrials.

  • Broadwood Capital's biggest Q3 2024 reduction was iShares Russell 2000 ETF, cutting an estimated $9.86M.
  • Broadwood Capital's ten largest holdings make up 100% of its $1.3B portfolio in Q3 2024.
  • Broadwood Capital opened 0 new positions and closed 0 in Q3 2024.
  • Broadwood Capital's portfolio value fell 1.4% quarter-over-quarter to $1.3B.

Based on Broadwood Capital's 13F filing for Q3 2024, filed 14 Nov 2024.